“Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis”, mfm, vol. 26, no. 5, May 2024, Accessed: Nov. 17, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2774